ahlam1399
09-19-2016, 07:00 PM
Astellas, Vical herpes vaccine fails mid-stage study
(Reuters) - Japan's Astellas Pharma Inc and San Diego-based Vical Inc said their experimental herpes vaccine failed a mid-stage study involving certain kidney transplant patients.http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=H-Lfdg8fyrE:xtHHDvXJgfo:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=H-Lfdg8fyrE:xtHHDvXJgfo:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=H-Lfdg8fyrE:xtHHDvXJgfo:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=H-Lfdg8fyrE:xtHHDvXJgfo:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=H-Lfdg8fyrE:xtHHDvXJgfo:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/H-Lfdg8fyrE
(Reuters) - Japan's Astellas Pharma Inc and San Diego-based Vical Inc said their experimental herpes vaccine failed a mid-stage study involving certain kidney transplant patients.http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=H-Lfdg8fyrE:xtHHDvXJgfo:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=H-Lfdg8fyrE:xtHHDvXJgfo:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=H-Lfdg8fyrE:xtHHDvXJgfo:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=H-Lfdg8fyrE:xtHHDvXJgfo:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=H-Lfdg8fyrE:xtHHDvXJgfo:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/H-Lfdg8fyrE